Hartig Drug Company has expanded its product lineup by adding Nefense® nasal care products at select locations in Iowa, Illinois, and Wisconsin, offering customers new drug-free options for daily nasal hygiene. The move addresses growing consumer interest in non-medicated approaches to respiratory wellness, particularly for routine nasal care.
The Nefense portfolio includes hypochlorous acid nasal sprays designed for adults, children, and infants, as well as a xylitol-based spray. These products provide alternatives to traditional decongestants, which can have side effects and are not suitable for prolonged use. By stocking these items, Hartig Drug aims to meet the needs of families seeking safe, effective, and drug-free solutions for nasal congestion and sinus health.
Published randomized clinical research has evaluated low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms and allergic rhinitis, showing promising results in reducing symptoms and improving quality of life. While these studies do not test Nefense-branded products directly, the underlying science supports the potential benefits of hypochlorous acid in nasal care. Nefense products are developed under the direction of Richard Downs, DDS, and are formulated with a focus on daily nasal hygiene and airway health.
Hartig Drug Company, a family-owned pharmacy and retail chain founded in Dubuque, Iowa, in 1904, serves communities across Iowa, Illinois, and Wisconsin. The addition of Nefense products aligns with its commitment to providing personalized service and a wide range of health and wellness items. Customers at select stores can now purchase these nasal care solutions, which are also available through Nefense's online platform at nefense.com.
The availability of Nefense in Hartig Drug stores represents a step forward in making drug-free nasal care more accessible to the public. As respiratory health remains a priority for many families, having non-medicated options on local pharmacy shelves could encourage more individuals to adopt proactive nasal hygiene practices. This is particularly relevant for parents of young children, who often seek gentler alternatives for managing congestion.
While the clinical evidence for hypochlorous acid is promising, experts note that more research is needed to fully understand its efficacy and optimal usage. Nonetheless, the introduction of these products into community pharmacies signals a growing trend toward integrative and preventive healthcare approaches. Hartig Drug's decision to carry Nefense may also reflect a broader shift among retailers to stock products that support immune health and everyday wellness without relying on pharmaceuticals.
For now, customers in Iowa, Illinois, and Wisconsin can visit participating Hartig Drug locations to explore the Nefense line. The company has not disclosed whether the products will be expanded to all stores in the future, but the initial rollout indicates a positive response to the demand for drug-free nasal care solutions.
